Allogene Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Allogene Therapeutics, Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from 2018 to 2023.
  • Allogene Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2024 was $8K.
  • Allogene Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $1.52M, a 70.8% decline from 2022.
  • Allogene Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $5.19M, a 75.8% decline from 2021.
  • Allogene Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2021 was $21.4M, a 67.5% decline from 2020.
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.52M -$3.68M -70.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $5.19M -$16.3M -75.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $21.4M -$44.5M -67.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 $66M +$15.2M +29.9% Jan 1, 2020 Dec 31, 2020 10-K/A 2024-03-14
2019 $50.8M +$47.6M +1471% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-23
2018 $3.23M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.